8 news items
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA
22 Jul 24
these benefits.Brain Penetration:P-gp is highly expressed
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
AEON
AES
AGRI
15 Jul 24
and firearm stocks traded higher following the attempted assassination of Donald Trump, which has lifted stocks that could benefit from a Trump presidency
MIRA Pharmaceuticals' Preclinical Study Shows MIRA-55's Enhanced Efficacy Over THC in Treating Anxiety and Cognitive Decline
MIRA
15 Jul 24
and prolonged therapeutic benefits, making it a more promising candidate for its target indications.
In studies exploring its potential
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA
15 Jul 24
-55 could provide more consistent and prolonged therapeutic benefits, making it a more promising candidate for its target indications.In studies
MIRA Announces Positive Test Results
MIRA
17 Jun 24
was given orally at the highest dose feasible and was found to be inactive. This points to the potential benefits of Ketamir-2—which is designed
r66rm6ctvfkdp27ngk5qn7i
MIRA
10 Jun 24
pointing to the comparative potential benefits of Ketamir-2, which is designed to be delivered orally
n04tnp5s97mqj685v1d bhy0s4pv7oqi0uif
MIRA
29 May 24
may deliver therapeutic benefits with minimal intoxicating effects. Unlike marijuana, MIRA-55 aims to provide these benefits without the associated
tl92wzi7k29 e4vuabyorde5u5i1imnmrq0y7ch98v40is391ixhk
MIRA
20 May 24
will be invaluable in demonstrating Ketamir-2's potential benefits. What sets Ketamir-2 apart from ketamine is its high oral bioavailability and lack of mu
- Prev
- 1
- Next